You're contacting media contact of this press release

Title: Genoscience Wins 2026 Global Award for High-Purity Research Peptides

Sarasota, Florida, United States, 27th Apr 2026 - Genoscience, a premier U.S. supplier of high-purity research peptides, announced it has received the 2026 Global Recognition Award. The company was honored for redefining institutional laboratory procurement through a secure supply chain built on domestic logistics, cGMP-compliant sourcing, and 99% analytical transparency.Founded by Kristelle Dammarell, Genoscience entered a scientific supply market flooded with unverified importers. Historically, scientists sourcing Research Peptides in the U.S. frequently encountered reagents of uncertain origin, jeopardizing the reproducibility of complex in-vitro assays. Genoscience solved this structural failure by building a specialized procurement model. As a dedicated scientific supplier, the company ensures its entire inventory is manufactured under strict Current Good Manufacturing Practice (cGMP) regulations, guaranteeing uncompromising batch-to-batch consistency for longitudinal studies.Today, when principal investigators are buying research peptides online, analytical verification is paramount. Operating on the principle of verifiable data, Genoscience mandates independent High-Performance Liquid Chromatography (HPLC) and mass spectrometry testing for every batch. This publicly available reporting ensures laboratories receive only High-Purity Research Peptides. Furthermore, Genoscience’s Sarasota-based fulfillment eliminates the risks of international customs delays, utilizing secure, climate-stable logistics to ensure lyophilized compounds arrive with their peptide bonds and structural conformations fully intact.Beyond secure procurement, the company supports the scientific community through the Genoscience Hub. This dedicated educational platform equips...

This press release is issued by King Newswire